Development of a new single dose extended release formulation of cefpodoxime proxetil
Open Access
- 28 February 2010
- journal article
- Published by Medknow in Asian Pacific Journal of Tropical Medicine
- Vol. 3 (2), 117-120
- https://doi.org/10.1016/s1995-7645(10)60048-x
Abstract
To develop floating microspheres of cefpodoxime proxetil (CP) in order to achieve an extended retention in the upper GIT for 12 hour. The microspheres were prepared by non aqueous solvent evaporation method using different ratios of cefpodoxime proxetil, hydroxyl propyl methyl cellulose (HPMC K4M) and ethyl cellulose (1:1:1, 1:1:2, 1:1:3, 1:1:4, 1:1:5 & 1:1:6), in the mixture of dichloromethane and ethanol at ratio of (1:1), with tween80 as the surfactant. The floating microspheres was extended over 10–12 hours and were characterized by particle size analysis (75–600μm), buoyancy percentage (68.1%–85.4%), drug entrapment efficiency (67.5%–88.8%), % yield (50.50%–77.31%) and in vitro drug release was studied for 12 hours. The floating microspheres show better result and it may be use full for prolong the drug release in stomach and improve the bioavailability.Keywords
This publication has 6 references indexed in Scilit:
- Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetilInternational Journal of Pharmaceutics, 2006
- Formulation strategies for absorption windowsDrug Discovery Today, 2005
- Cefpodoxime-proxetil protection from intestinal lumen hydrolysis by oil-in-water submicron emulsionsInternational Journal of Pharmaceutics, 1998
- In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centersDiagnostic Microbiology and Infectious Disease, 1993
- Floating and Swelling Characteristics of Various Excipients Used in Controlled Release TechnologyDrug Development and Industrial Pharmacy, 1993
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963